GSK3B and endometrial cancer: In addition to identifying well-known drivers, CHASM identified potential drivers not previously associated with endometrial cancer, in biologically relevant pathways: viz MTOR in the PI3K pathway and GSK-3B in the Wnt signalling pathway).